Fowler Neal Franklin's Form 4 filing
Emergent BioSolutions Inc. (EBS) · filed Mar 12, 2025
- Accession no.
- 0001367644-25-000060
- Filed
- Mar 12, 2025
- Trade date
- Mar 12, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $204.1K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fowler Neal FranklinCIK 0001493692 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2025 | Common Stock | SSaleDisposed | −35,000 | $5.83 | −$204,050 | 101,100 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.